Tirzepatide Telehealth by State

Availability is set programme by programme and governed by two licences. Here is what applies where you live.

Direct answer

12 of the 16 programmes we price publish availability in all fifty states. The rest publish narrower maps, and 7 states appear on exclusion lists in our sources.

Two licences have to line up for any shipment: the prescribing clinician must hold one in your state, and the dispensing pharmacy must be registered to ship into it. Gaps are regulatory rather than judgements about patients, and they change without notice.

First-year all-in cost

NexLife$2,580Yucca Health$3,096IVIM Health$3,219ShedRx$3,318Mochi Health$3,336Found$3,468SkinnyRx$3,588Amble Health$3,600Lavender Sky Health$3,971Henry Meds$4,188
Two months of titration plus ten at a 10 mg maintenance dose, membership included. Captured 2026-08-05.
All 51 jurisdictions with their exclusion status in our sources. Captured 2026-08-05.
StateAbbrRegionExclusion status
AlabamaALSouthflagged
AlaskaAKWestno exclusion recorded
ArizonaAZWestno exclusion recorded
ArkansasARSouthflagged
CaliforniaCAWestflagged
ColoradoCOWestno exclusion recorded
ConnecticutCTNortheastno exclusion recorded
DelawareDESouthno exclusion recorded
FloridaFLSouthno exclusion recorded
GeorgiaGASouthno exclusion recorded
HawaiiHIWestno exclusion recorded
IdahoIDWestno exclusion recorded
IllinoisILMidwestno exclusion recorded
IndianaINMidwestno exclusion recorded
IowaIAMidwestno exclusion recorded
KansasKSMidwestno exclusion recorded
KentuckyKYSouthno exclusion recorded
LouisianaLASouthflagged
MaineMENortheastno exclusion recorded
MarylandMDSouthno exclusion recorded
MassachusettsMANortheastno exclusion recorded
MichiganMIMidwestno exclusion recorded
MinnesotaMNMidwestno exclusion recorded
MississippiMSSouthflagged
MissouriMOMidwestno exclusion recorded
MontanaMTWestno exclusion recorded
NebraskaNEMidwestno exclusion recorded
NevadaNVWestflagged
New HampshireNHNortheastno exclusion recorded
New JerseyNJNortheastno exclusion recorded
New MexicoNMWestno exclusion recorded
New YorkNYNortheastno exclusion recorded
North CarolinaNCSouthno exclusion recorded
North DakotaNDMidwestno exclusion recorded
OhioOHMidwestno exclusion recorded
OklahomaOKSouthno exclusion recorded
OregonORWestno exclusion recorded
PennsylvaniaPANortheastno exclusion recorded
Rhode IslandRINortheastno exclusion recorded
South CarolinaSCSouthno exclusion recorded
South DakotaSDMidwestno exclusion recorded
TennesseeTNSouthno exclusion recorded
TexasTXSouthno exclusion recorded
UtahUTWestno exclusion recorded
VermontVTNortheastno exclusion recorded
VirginiaVASouthno exclusion recorded
WashingtonWAWestno exclusion recorded
West VirginiaWVSouthno exclusion recorded
WisconsinWIMidwestno exclusion recorded
WyomingWYWestno exclusion recorded
Washington, D.C.DCSouthflagged

The failure mode this section guards against

Choosing a programme on a number that describes a different situation than yours. An entry price when you will hold maintenance. A medication figure when a membership applies. A promotional rate when you will renew.

Each error is small alone and they compound in one direction, which is why the cheapest-looking option in most published comparisons is the one most likely to be mis-stated. Priced correctly the cheapest verified route sits at $215 a month all-in at a 10 mg maintenance dose.

Why we publish the working rather than a verdict

A single recommendation reads better and acts worse, because it hides the weighting. Two readers with different maintenance doses, different coverage and different tolerance for commitment should not receive the same answer.

So the tables carry the inputs and every ranking states its sort key. Disagree with our weighting and you can take the file and weight it yourself — which is what publishing it is for.

The number most people get wrong

The month-six figure. Almost everyone budgets from the first month, which on tirzepatide describes four weeks at 2.5 mg — roughly 10 mg of active drug against the 40 mg a maintenance month delivers.

Ten of your first twelve months are spent at or near maintenance. A ranking sorted on the advertised month is sorting on about eight per cent of your year, and on a dose-scaled programme those are different numbers entirely.

Run the first-year calculator at the dose you expect to hold. It takes under a minute and it reorders the market for most people.

What a year of this actually looks like

Four weeks at 2.5 mg, four at 0.5 mg, four at 1 mg, four at 1.7 mg, then 10 mg for the remainder. Eight to twelve weeks of titration if nothing is repeated, and repeats are common rather than exceptional.

Budget two extra months at a lower tier and treat anything better as upside. Fix a weekly injection day, record dose and date, and diary the renewal date if an introductory rate applies — the reversion is where most complaints in this category begin.

Primary sources

Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.

  1. NABP — State Boards of Pharmacy directory
  2. FDA — Human Drug Compounding
  3. FDA — Compounding and the FDA: Questions and Answers
  4. Medicare.gov

Next step

Compare every programme on one screen

The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.

Open the comparison matrix How all-in cost is calculated